Merck Settles Nuvaring Litigation Commenced by Attorney Jason T. Brown for 100 Million Dollars

Attorney Jason T. Brown whose practice focuses on Mass Torts and Class Actions confirmed that the Mult-District Mass Tort Litigation concerning blood clots allegedly caused from the Nuvaring has settled for $100,000,000.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
"This was a hard fight and a fair result." - Attorney Jason T. Brown of The JTB Law Group, LLC

New York, New York (PRWEB) February 07, 2014

A settlement fund of $100 million dollars on behalf of women who were allegedly injured by the birth control product Nuvaring was announced today in New Jersey State Court and Federal Court. (In Re Nuvaring Litigation – Case 284, Bergen County, New Jersey). Attorney Jason T. Brown, the first attorney in the country to commence a battery of these cases against Nuvaring confirmed the settlement was unsealed today in open court. Jason T. Brown, a former FBI Agent, who presently handles class actions and mass torts nationwide indicated that the settlement was fair and just. “This settlement allows an avenue of recovery for women who alleged in their complaints that they endured blood clots such as Deep-Vein Thrombosis, Pulmonary Embolisms, Strokes and Death. There are strict deadlines contained in the settlement and any woman who has counsel should consult with their counsel as soon as possible,” Mr. Brown stated.

In 2006, Jason T Brown took on pharmaceutical giants by commencing lawsuits against the makers of the hormonal birth control product NuvaRing. The product passed though the hands of Organon, Schering-Plough and the billion dollar pharmaceutical company Merck. After 8 years of fighting, hundreds of depositions worldwide, trial calls that came and went and relentless litigation from both sides the case settled for $100,000,000 (one hundred million dollars). (http://www.reuters.com/article/2014/02/06/merck-settlement-idUSL2N0LB27M20140206).

The settlement agreement is extensive and calls for 95% participation rate in a short time frame to become effective. Mr. Brown hailed the result as a victory and commended the hard work put in by a multitude of forces to make this a success.

Mr. Brown’s firm remains active in the birth control litigation front, also handling settlements on behalf of women who allegedly sustained blood clots, such as deep vein thrombosis, pulmonary embolisms, strokes and death from the products like Yaz, Yasmin, Ocella, Gianvi, and Beyaz.* Additionally, the firm is investigating heart attacks and other blood clots from products like Androgel, after the FDA indicated it was investigating them.**

About Jason T. Brown – Mr. Brown was a former Legal Advisor and Special Agent with the Federal Bureau of Investigation (FBI). He went into private law practice and became the managing partner of a law firm that handled class actions and mass torts. Presently, he is trial attorney in high demand and travels nationwide litigating cases. The firm handles pharmaceutical litigation such as Yaz, Yasmin, Ocella, Pradaxa, TVM, SSRI birth defects and other matters involving catastrophic injury. His current firm the JTB Law Group can be found at http://www.IFightForYourRights.com.


Contact